{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:51:34Z","timestamp":1785534694661,"version":"3.56.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:p>Variants in genes encoding for voltage-gated K<jats:sup>+<\/jats:sup> (Kv) channels are frequent cause of drug-resistant pediatric epilepsies. Obtaining a molecular diagnosis gives the opportunity to assess the efficacy of pharmacological strategies based on <jats:italic>in vitro<\/jats:italic> features of mutant channels. In this retrospective observational study, we selected patients with drug-resistant pediatric epilepsies caused by variants in potassium channel encoding genes, followed at the Fondazione IRCCS Istituto Neurologico Carlo Besta of Milan, Italy. After the experimental characterization of variants\u2019 functional properties in transiently transfected Chinese Hamster Ovary (CHO) cells, we identified drugs to be used as pharmacological approaches. We recruited six patients carrying different missense variants in four Kv channels (Kv7.2, Kv7.3, Kv3.1, and K<jats:sub>Na<\/jats:sub>1.1). <jats:italic>In vitro<\/jats:italic> experiments demonstrated that variants in Kv7 channels induced loss-of-function (LoF) effects, while those affecting Kv3.1 or K<jats:sub>Na<\/jats:sub>1.1 led to gain-of-function (GoF). Moreover, we found that the Kv7 channels activator gabapentin was able to revert the LoF effects caused by Kv7.2\/Kv7.3 variants, and the potassium channel-blocker fluoxetine counteracted the GoF effects in Kv3.1 or K<jats:sub>Na<\/jats:sub>1.1 variants. According to experimental data, patients carrying Kv7 variants were treated with gabapentin. While this treatment resulted successful in two patients (#1, Kv7.2 G310S variant; #3, Kv7.3 V359L\u202f+\u202fKv7.3 D542N), it resulted detrimental in the remaining case (#2, Kv7.2 D535E), requiring drug withdrawal. The application <jats:italic>in vivo<\/jats:italic> of fluoxetine to counteract GoF effects induced by Kv3.1 or K<jats:sub>Na<\/jats:sub>1.1 variants determined a significant reduction of both seizure frequency and behavior disturbances in patient #4 (Kv3.1 V425M), and in both subjects carrying K<jats:sub>Na<\/jats:sub>1.1 variants (#5, S937G and #6, R262Q). However, for the latter case, this drug was halted due to severe behavioral side effects. For most of the patients herein reported, pharmacological strategies, selected according to the <jats:italic>in vitro<\/jats:italic> functional properties of Kv-channels pathogenic variants, resulted in a significant improvement of both epileptic and cognitive features.<\/jats:p>","DOI":"10.3389\/fncel.2024.1512365","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T07:14:00Z","timestamp":1737702840000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes"],"prefix":"10.3389","volume":"18","author":[{"given":"Ilaria","family":"Filareto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Freri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ragona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Canafoglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Solazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Castellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Gellera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Virginia","family":"Soldovieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ambrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Taglialatela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo C.","family":"DiFrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.seizure.2017.11.017","article-title":"Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature","volume":"55","author":"Abdelnour","year":"2018","journal-title":"Seizure"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1007\/s12035-018-0883-5","article-title":"Kv7.3 compound heterozygous variants in early onset encephalopathy reveal additive contribution of C-terminal residues to PIP","volume":"55","author":"Ambrosino","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1111\/epi.17656","article-title":"A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: \u201cprecision medicine\u201d approach with fluoxetine","volume":"64","author":"Ambrosino","year":"2023","journal-title":"Epilepsia"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.phrs.2014.06.015","article-title":"Functional and biochemical interaction between PPAR\u03b1 receptors and TRPV1 channels: potential role in PPAR\u03b1 agonists-mediated analgesia","volume":"87","author":"Ambrosino","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1412420","DOI":"10.3389\/fphar.2024.1412420","article-title":"The multifaceted effects of fluoxetine treatment on cognitive functions","volume":"15","author":"Ampuero","year":"2024","journal-title":"Front. Pharmacol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J. Neurochem."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/genes12071051","article-title":"Epilepsy syndromes in the first year of life and usefulness of genetic testing for precision therapy","volume":"12","author":"Bayat","year":"2021","journal-title":"Genes"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1093\/brain\/awab219","article-title":"KCNT1 -related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum","volume":"144","author":"Bonardi","year":"2021","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/epi.16480","article-title":"KCNT1-related epilepsy: an international multicenter cohort of 27 pediatric cases","volume":"61","author":"Borlot","year":"2020","journal-title":"Epilepsia"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/acn3.50822","article-title":"Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations","volume":"6","author":"Cameron","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/epi4.13039","article-title":"Next-generation sequencing in pediatric-onset epilepsies: analysis with target panels and personalized therapeutic approach","volume":"9","author":"Castellotti","year":"2024","journal-title":"Epilepsia Open."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0028-3908(01)00088-0","article-title":"Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1","volume":"41","author":"Choi","year":"2001","journal-title":"Neuropharmacology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.mayocp.2016.10.011","article-title":"Selective serotonin reuptake inhibitors and Poststroke epilepsy: a population-based Nationwide study","volume":"92","author":"Chou","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0219137","DOI":"10.1371\/journal.pone.0219137","article-title":"Selective serotonin reuptake inhibitors and risk of epilepsy after traumatic brain injury - a population based cohort study","volume":"14","author":"Christensen","year":"2019","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/acn3.51707","article-title":"A KCNC1 -related neurological disorder due to gain of Kv3.1 function","volume":"10","author":"Clatot","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s13311-018-0657-9","article-title":"Early treatment with quinidine in 2 patients with epilepsy of infancy with migrating focal seizures (EIMFS) due to gain-of-function KCNT1 mutations: functional studies, clinical responses, and critical issues for personalized therapy","volume":"15","author":"Dilena","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"942582","DOI":"10.3389\/fneur.2022.942582","article-title":"Case report: effect of targeted therapy with carbamazepine in KCNQ2 neonatal epilepsy","volume":"13","author":"Dilena","year":"2022","journal-title":"Front. Neurol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/a-2060-4576","article-title":"KCNQ2-related epilepsy: genotype\u2013phenotype relationship with tailored antiseizure medication (ASM)\u2014a systematic review","volume":"54","author":"Falsaperla","year":"2023","journal-title":"Neuropediatrics"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s13311-019-00739-y","article-title":"Treatment responsiveness in KCNT1-related epilepsy","volume":"16","author":"Fitzgerald","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10072-022-06521-x","article-title":"New use for an old drug: quinidine in KCNT1-related epilepsy therapy","volume":"44","author":"Liu","year":"2023","journal-title":"Neurol. Sci."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/B978-0-444-63326-2.00002-8","article-title":"Potassium channel genes and benign familial neonatal epilepsy","volume":"213","author":"Maljevic","year":"2014","journal-title":"Prog. Brain Res."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1124\/mol.118.112953","article-title":"Gabapentin is a potent activator of KCNQ3 and KCNQ5 potassium channels","volume":"94","author":"Manville","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1212\/WNL.0000000000004762","article-title":"Clinical and molecular characterization of KCNT1 -related severe early-onset epilepsy","volume":"90","author":"McTague","year":"2018","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1523\/JNEUROSCI.4423-14.2015","article-title":"Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of K v 7.2 and K v 7.3 Potassium Channel subunits","volume":"35","author":"Miceli","year":"2015","journal-title":"J. Neurosci."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ana.24128","article-title":"KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine","volume":"75","author":"Milligan","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/14737159.2019.1573144","article-title":"From next-generation sequencing to targeted treatment of non-acquired epilepsies","volume":"19","author":"M\u00f8ller","year":"2019","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2020.12.001","article-title":"Early-onset developmental and epileptic encephalopathies of infancy: an overview of the genetic basis and clinical features","volume":"116","author":"Morrison-Levy","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1367838","DOI":"10.3389\/fncel.2024.1367838","article-title":"Case report: marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy","volume":"18","author":"Mosca","year":"2024","journal-title":"Front. Cell. Neurosci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"872645","DOI":"10.3389\/fphar.2022.872645","article-title":"Functional characterization of two variants at the intron 6-exon 7 boundary of the KCNQ2 Potassium Channel gene causing distinct epileptic phenotypes","volume":"13","author":"Mosca","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1212\/WNL.0000000000004769","article-title":"Precision therapy for epilepsy due to KCNT1 mutations: a randomized trial of oral quinidine","volume":"90","author":"Mullen","year":"2018","journal-title":"Neurology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00424-020-02404-2","article-title":"Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction","volume":"472","author":"Nappi","year":"2020","journal-title":"Pflugers Arch."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/epi.12984","article-title":"Early and effective treatment of KCNQ2 encephalopathy","volume":"56","author":"Pisano","year":"2015","journal-title":"Epilepsia"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1528-1167.2010.02908.x","article-title":"The serotonin axis: shared mechanisms in seizures, depression, and SUDEP","volume":"52","author":"Richerson","year":"2011","journal-title":"Epilepsia"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mcn.2016.01.004","article-title":"Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy","volume":"72","author":"Rizzo","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/epi.13596","article-title":"Rapid and safe response to low-dose carbamazepine in neonatal epilepsy","volume":"57","author":"Sands","year":"2016","journal-title":"Epilepsia"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-024-00546-6","article-title":"Developmental and epileptic encephalopathies","volume":"10","author":"Scheffer","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1113\/jphysiol.2002.028571","article-title":"Molecular correlates of the M-current in cultured rat hippocampal neurons","volume":"544","author":"Shah","year":"2002","journal-title":"J. Physiol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"17562864231191000","DOI":"10.1177\/17562864231191000","article-title":"Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies","volume":"16","author":"Sills","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1093\/brain\/awg286","article-title":"KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum","volume":"126","author":"Singh","year":"2003","journal-title":"Brain"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1523\/JNEUROSCI.0580-07.2007","article-title":"Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions","volume":"27","author":"Soldovieri","year":"2007","journal-title":"J. Neurosci."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"105200","DOI":"10.1016\/j.phrs.2020.105200","article-title":"Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy","volume":"160","author":"Soldovieri","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/brain\/awaa371","article-title":"Developmental and epileptic encephalopathies: what we do and do not know","volume":"144","author":"Specchio","year":"2021","journal-title":"Brain"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"11870","DOI":"10.1074\/jbc.M111.336511","article-title":"The Kv7.2\/Kv7.3 heterotetramer assembles with a random subunit arrangement","volume":"287","author":"Stewart","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1254\/jphs.FP0070759","article-title":"Open Channel block of Kv3.1 currents by fluoxetine","volume":"106","author":"Sung","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/epi4.12348","article-title":"Possible precision medicine implications from genetic testing using combined detection of sequence and intragenic copy number variants in a large cohort with childhood epilepsy","volume":"4","author":"Truty","year":"2019","journal-title":"Epilepsia Open"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1212\/01.wnl.0000435296.72400.a1","article-title":"Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients","volume":"81","author":"Weckhuysen","year":"2013","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ana.22644","article-title":"KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy","volume":"71","author":"Weckhuysen","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/epi.17237","article-title":"Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE task force on nosology and definitions","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1111\/bcp.15479","article-title":"Precision therapy with quinidine of KCNT1-related epileptic disorders: a systematic review","volume":"88","author":"Xu","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.neuropharm.2006.06.003","article-title":"Pharmacological activation and inhibition of slack (Slo2.2) channels","volume":"51","author":"Yang","year":"2006","journal-title":"Neuropharmacology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/epi.17239","article-title":"ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE task force on nosology and definitions","volume":"63","author":"Zuberi","year":"2022","journal-title":"Epilepsia"}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2024.1512365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T07:14:03Z","timestamp":1737702843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2024.1512365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":55,"alternative-id":["10.3389\/fncel.2024.1512365"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2024.1512365","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"article-number":"1512365"}}